Logica COVID-19 FHIR Profile Library IG
0.10.1 - CI Build

Logica COVID-19 FHIR Profile Library IG - Local Development build (v0.10.1). See the Directory of published versions

Table of Contents

..0 Table of Contents
...1 Home
...2 Logica Comparison to E ICR
...3 Patient Demographics and Vital Signs
...4 Case Reporting Info
...5 Exposure Info
...6 Signs Symptoms Diagnoses Comorbidities
...7 Lab Profiles
...8 Smoking Status Pregnancy Status
...9 Exposure Questionnaire
...10 History
...11 Artifacts Summary
....11.1 COVID 19 Exposure Core profile
....11.2 Coded Laboratory Observation Base
....11.3 Laboratory Observation Base
....11.4 Laboratory Observation Panel Base
....11.5 Quantitative Laboratory Observation Base
....11.6 COVID 19 Exposure Questionnaire
....11.7 COVID-19 gastrointestinal and hepatic underlying condition
....11.8 COVID-19 hemoglobinopathy underlying condition
....11.9 COVID-19 ICD 10 Diagnosis
....11.10 COVID-19 immune underlying condition
....11.11 COVID-19 renal underlying condition
....11.12 COVID-19 respiratory underlying condition
....11.13 COVID-19 SNOMED Diagnosis
....11.14 COVID 19 Symptoms Absent
....11.15 COVID 19 Symptoms Present
....11.16 COVID-19 uncategorized underlying condition
....11.17 COVID-19 cardiovascular underlying condition
....11.18 COVID-19 immunocompromised underlying condition
....11.19 COVID-19 General Comorbidities Absent
....11.20 COVID-19 General Comorbidities Present
....11.21 COVID-19 metabolic underlying condition
....11.22 COVID-19 neurologic underlying condition
....11.23 Case-Patient Report Identifying Information
....11.24 Exposure Type
....11.25 Influenza virus A and B RNA and SARS-CoV-2 (COVID-19) N gene panel - Respiratory specimen by NAA with probe detection
....11.26 Influenza virus A and B and SARS-CoV-2 (COVID-19) identified in Respiratory specimen by NAA with probe detection
....11.27 Influenza virus A and B and SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection
....11.28 Influenza virus A RNA [Presence] in Respiratory specimen by NAA with probe detection
....11.29 Influenza virus B RNA [Presence] in Respiratory specimen by NAA with probe detection
....11.30 Gestational Age at Onset of Illness
....11.31 Human coronavirus 229E+HKU1+OC43+NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection
....11.32 Human coronavirus 229E RNA [Presence] in Nasopharynx by NAA with non-probe detection
....11.33 Human coronavirus HKU1 RNA [Presence] in Nasopharynx by NAA with non-probe detection
....11.34 Human coronavirus NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection
....11.35 Human coronavirus OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection
....11.36 Known Exposure
....11.37 Pregnancy Status
....11.38 SARS-CoV-2 (COVID19) IgG Ab [Presence] in DBS by Immunoassay
....11.39 SARS-CoV-2 (COVID19) Ab [Units/volume] in Serum or Plasma by Immunoassay
....11.40 SARS-CoV-2 (COVID19) IgA Ab [Presence] in Serum, Plasma, or Blood by Rapid imunoassay
....11.41 SARS-CoV-2 (COVID19) IgA + IgM [Presence] in Serum or Plasma by Immunoassay
....11.42 SARS-CoV-2 (COVID19) Ab [Presence] in Serum or Plasma by Immunoassay
....11.43 SARS-CoV-2 (COVID19) Ag [Presence] in Respiratory specimen by Rapid immunoassay
....11.44 SARS-CoV-2 (COVID19) E gene [Presence] in Respiratory specimen by NAA with probe detection
....11.45 SARS-CoV-2 (COVID19) E gene [Presence] in Serum or Plasma by NAA with probe detection
....11.46 SARS-CoV-2 (COVID19) N gene [Presence] in Nasopharynx by NAA with probe detection
....11.47 SARS-CoV-2 (COVID19) N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N1
....11.48 SARS-CoV-2 (COVID19) N gene [Presence] in Respiratory specimen by Nucleaic acid amplification using CDC primer-probe set N2
....11.49 SARS-CoV-2 (COVID19) N gene [Presence] in Serum or Plasma by NAA with probe detection
....11.50 SARS-CoV-2 (COVID19) N gene [Presence] in Unspecified specimen by Nucleic acid amplification using primer-probe set N1
....11.51 SARS-CoV-2 (COVID19) N gene [Presence] in Unspecified specimen by Nucleic acid amplification using primer-probe set N2
....11.52 SARS-CoV-2 (COVID19) N gene [Cycle Threshold #] in Unspecified specimen by Nucleic acid amplification using primer-probe set N1
....11.53 SARS-CoV-2 (COVID19) N gene [Cycle Threshold #] in Unspecified specimen by Nucleic acid amplification using primer-probe set N2
....11.54 SARS-CoV-2 (COVID19) ORF1ab region [Presence] in Respiratory specimen by NAA with probe detection
....11.55 SARS-CoV-2 (COVID19) [Presence] in Unspecified specimen by Organism specific culture
....11.56 SARS-CoV-2 (COVID19) RNA [Cycle Threshold#] in Respiratory specimen by NAA with probe detection
....11.57 SARS-CoV-2 (COVID19) RNA [Log#/volume] (viral load) in Unspecified specimen by NAA with probe detection
....11.58 SARS-Cov-2 (COVID19) RNA panel - Unspecified specimen by NAA with probe detection
....11.59 Sars-CoV-2 (COVID19) RNA [Presence] in Nasopharynx by NAA with probe detection
....11.60 SARS-CoV-2 (COVID19) RNA [Presence] in Saliva (oral fluid) by NAA with probe
....11.61 SARS-CoV-2 (COVID19) RNA [Presence] in Saliva (oral fluid) by Sequencing
....11.62 SARS-CoV-2 (COVID19) RNA [Cycle Threshold#] in Unspecified specimen by NAA with probe detection
....11.63 SARS-CoV-2 (COVID19) S gene [Presence] in Serum or Plasma by NAA with probe detection
....11.64 SARS-coV-2 (COVID19) whole genome [Nucleiotide sequence] in Isolate by Sequencing
....11.65 SARS-CoV + SARS-Cov-2 (COVID19) Ag [Presence] in Respiratory specimen by Rapid immunoassay
....11.66 SARS-like coronavirus N gene [Presence] in Unspecified specimen by NAA with probe detection
....11.67 SARS-like coronavirus N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection
....11.68 SARS-related coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection
....11.69 SARS-CoV-2 (COVID19) IgA Ab [Units/volume] in Serum or Plasma by Immunoassay
....11.70 SARS-CoV-2 (COVID19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
....11.71 SARS-CoV-2 (COVID-19) IgA Ab [Titer] in Serum or Plasma by Immunofluorescence
....11.72 SARS-CoV-2 (COVID19) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
....11.73 SARS-CoV-2 (COVID-19) IgG+IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
....11.74 SARS-CoV-2 (COVID19) IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay
....11.75 SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
....11.76 SARS-CoV-2 (COVID19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
....11.77 SARS-CoV-2 (COVID-19) IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
....11.78 SARS-CoV-2 (COVID19) IgG and IgM panel - Serum or Plasma Qualitative by Rapid immunoassay
....11.79 SARS-CoV-2 (COVID19) IgG and IgM panel - Serum or Plasma by Immunoassay
....11.80 SARS-CoV-2 (COVID19) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
....11.81 SARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay
....11.82 SARS-CoV-2 (COVID19) IgM Ab [Presence] in Serum or Plasma by Immunoassay
....11.83 SARS-CoV-2 (COVID19) IgM Ab [Presence] in Serum or Plasma by Rapid immunoassay
....11.84 SARS-CoV-2 (COVID-19) IgM Ab [Titer] in Serum or Plasma by Immunofluorescence
....11.85 SARS-CoV-2 (COVID19) Ab [Interpretation] in Serum or Plasma
....11.86 SARS-CoV-2 (COVID-19) neutralizing antibody [Presence] in Serum by pVNT
....11.87 SARS-CoV-2 (COVID-19) neutralizing antibody [Titer] in Serum by pVNT
....11.88 SARS-CoV-2 (COVID19) E gene [Presence] in Unspecified specimen by NAA with probe detection
....11.89 SARS-CoV-2 (COVID19) E gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection
....11.90 SARS-CoV-2 (COVID-19) N gene [Log #/volume] (viral load) in Respiratory specimen by NAA with probe detection
....11.91 SARS-CoV-2 (COVID-19) N gene [#/volume] (viral load) in Respiratory specimen by NAA with probe detection
....11.92 SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with probe detection
....11.93 SARS-CoV-2 (COVID19) N gene [Presence] in Respiratory specimen by NAA with probe detection
....11.94 SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection
....11.95 SARS-CoV-2 (COVID19) N gene [Presence] in Unspecified specimen by NAA with probe detection
....11.96 SARS-CoV-2 (COVID19) N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection
....11.97 SARS-CoV-2 (COVID19) ORF1ab region [Cycle Threshold #] in Unspecified specimen by NAA with probe detection
....11.98 SARS-CoV-2 (COVID19) ORF1ab region [Presence] in Unspecified specimen by NAA with probe detection
....11.99 SARS-CoV-2 (COVID19) ORF1ab region [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
....11.100 SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Respiratory specimen by NAA with probe detection
....11.101 SARS-CoV-2 (COVID19) RNA panel - Respiratory specimen by NAA with probe detection
....11.102 SARS-CoV-2 (COVID-19) RNA [Presence] in Nose by NAA with probe detection
....11.103 SARS-CoV-2 (COVID19) RNA [Presence] in Nasopharynx by NAA with non-probe detection
....11.104 SARS-CoV-2 (COVID19) RNA [Presence] in Respiratory specimen by NAA with probe detection
....11.105 SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by Sequencing
....11.106 SARS-CoV-2 (COVID19) RNA [Presence] in Serum or Plasma by NAA with probe detection
....11.107 SARS-CoV-2 (COVID19) RNA [Presence] in Unspecified specimen by NAA with probe detection
....11.108 SARS-CoV-2 (COVID19) RdRp gene [Presence] in Respiratory specimen by NAA with probe detection
....11.109 SARS-CoV-2 (COVID19) RdRp gene [Presence] in Unspecified specimen by NAA with probe detection
....11.110 SARS-CoV-2 (COVID19) RdRp gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
....11.111 SARS-CoV-2 (COVID19) RdRp gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection
....11.112 SARS-CoV-2 (COVID-19) S gene [Presence] in Unspecified specimen by NAA with probe detection
....11.113 SARS-CoV-2 (COVID19) S gene [Presence] in Respiratory specimen by NAA with probe detection
....11.114 SARS-CoV-2 (COVID19) S gene [Presence] in Unspecified specimen by NAA with probe detection
....11.115 SARS-CoV-2 (COVID19) S gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
....11.116 SARS-CoV-2 (COVID19) S gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection
....11.117 SARS-related coronavirus+MERS coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection
....11.118 SARS-related coronavirus RNA [Presence] in Unspecified specimen by NAA with probe detection
....11.119 Tobacco smoking status
....11.120 Travel History
....11.121 Certainty of Absence
....11.122 Certainty of Presence
....11.123 Reporting Priority
....11.124 COVID-19 cardiovascular underlying condition reference set
....11.125 COVID-19 Disease Severity Value Set
....11.126 COVID-19 ICD 10 Diagnosis Value Set
....11.127 COVID-19 SNOMED CT Diagnosis Value Set
....11.128 COVID-19 Signs and Symptoms Severity Value Set
....11.129 COVID-19 Signs and Symptoms Value Set
....11.130 COVID-19 uncategorized underlying condition reference set
....11.131 COVID-19 gastrointestinal or hepatic underlying condition reference set
....11.132 COVID-19 hemoglobinopathy underlying condition reference set
....11.133 COVID-19 immune underlying condition reference set
....11.134 COVID-19 immunocompromised underlying condition reference set
....11.135 COVID-19 Underlying Medical Condition Value Set
....11.136 COVID-19 metabolic underlying condition reference set
....11.137 COVID-19 neurologic underlying condition reference set
....11.138 COVID-19 renal underlying condition reference set
....11.139 COVID-19 respiratory underlying condition reference set
....11.140 Certainty of Absence Value Set
....11.141 Certainty of Presence Value Set
....11.142 Close Contact Setting Value Set
....11.143 Country Codes Value Set
....11.144 Detected-Not Detected-Inconclusive Value Set
....11.145 Influenza A, Influenza B, SARS CoV 2, and SARS CoV value set
....11.146 Influenza A, Influenza B, and SARS CoV2 value set
....11.147 HL7 Yes/No value set
....11.148 Healthcare Occupation Value Set
....11.149 ISO Code System 3166 country codes
....11.150 ISO Code System 3166 state/province codes.
....11.151 Known Exposure LOINC Answer Value Set
....11.152 Positive/Negative Value Set
....11.153 Pregnancy Status Value Set
....11.154 Reporting Priorities Value Set
....11.155 Smoking Status Value Set
....11.156 State Codes Value Set
....11.157 Yes/No Value Set